- Home
- CORT vs BKV Comparison
CORT vs BKV Comparison
Compare CORT & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CORT | BKV |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | 452 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.0B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | CORT | BKV |
|---|---|---|
| Price | $42.51 | $27.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $107.20 | $33.25 |
| AVG Volume (30 Days) | ★ 1.8M | 1.0M |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $761,407,000.00 | N/A |
| Revenue This Year | $26.08 | $69.06 |
| Revenue Next Year | $31.04 | $11.32 |
| P/E Ratio | ★ $51.84 | $57.07 |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $15.00 |
| 52 Week High | $91.00 | $32.81 |
Technical Indicators
Market Signals| Indicator | CORT | BKV |
|---|---|---|
| Relative Strength Index (RSI) | 65.95 | 39.98 |
| Support Level | $32.95 | $25.10 |
| Resistance Level | $47.06 | $28.34 |
| Average True Range (ATR) | 2.67 | 1.06 |
| MACD | 1.20 | -0.18 |
| Stochastic Oscillator | 56.92 | 12.65 |
Price Performance
Historical ComparisonAbout CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About BKV BKV Corporation
BKV Corp is a growth-driven energy company focused on the development of natural gas-producing assets, the ownership and operation of natural gas-fired power generation assets, and selective accretive acquisitions. The company's core businesses are the production of natural gas and the generation of natural gas-fired power from its owned and operated assets, supported by a closed-loop plan, enabled by its upstream, midstream, power, and CCUS businesses.